AJR Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakaura, T.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakaura, T.
Right arrow Articles by Yamashita, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2207
AJR 2008; 190:W13-W18
© American Roentgen Ray Society


Original Research

Detection of Early Enhancement of Hypervascular Hepatocellular Carcinoma Using Single Breath-Hold 3D Pixel Shift Dynamic Subtraction MDCT

Takeshi Nakaura1, Kazuo Awai, Yumi Yanaga, Yoshiharu Nakayama, Seitaro Oda, Yoshinori Funama and Yasuyuki Yamashita

1 All authors: Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjyo, Kumamoto 860-8556, Japan.

OBJECTIVE. The objective of our study was to evaluate the effect of single breath-hold dynamic subtraction MDCT of the liver on the performance of radiologists in detecting focal enhancement during the hepatic arterial phase.

SUBJECTS AND METHODS. This prospective study included 40 patients: 22 had hypervascular hepatocellular carcinoma (HCC), and 18 were without liver tumors. We obtained four-phase contrast-enhanced scans using a 16-MDCT unit. The section thickness and interval were 2 and 0.5 mm, respectively. Scanning for the first through fourth scans was started 10, 35, 70, and 180 seconds after the inception of contrast injection, respectively. Scanning for the first and second phase was within a single breath-hold. We subtracted the first-phase images from the second-phase images using software developed in-house. We used receiver operating characteristic (ROC) analysis with a continuous rating scale from 1 to 100 to compare observer performance in the detection of focal enhancement on second-phase images. Eight radiologists participated in the observer performance test, and their performances with unenhanced and contrast-enhanced original images were compared with their performances using contrast-enhanced subtracted images.

RESULTS. For the eight observers, the mean area under the best-fit ROC curve (Az) values without and with the subtracted images were 0.86 ± 0.05 (SD) and 0.91 ± 0.03, respectively. The difference was significant (p < 0.01, two-tailed paired Student's t test).

CONCLUSION. The display of subtracted images significantly improved the diagnostic performance of radiologists in the detection of focal enhancement during the hepatic arterial phase (p < 0.01).

Keywords: cirrhosis • hemodynamics • hepatocellular carcinoma • liver disease • MDCT • oncologic imaging • subtraction MDCT


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.